Examining the Dublin and Sligo participant datasets separately, the weighted prevalence of antibodies to SARS-CoV-2 among HCW was almost twice that observed for non-HCW in both sites (in Dublin 5.78% (95% CI: 1.13–16.38) vs 3.00% (95% CI: 1.92–4.45); in Sligo 1.32% (95% CI: 0.03–7.52) vs 0.52% (95% CI: 0.14–1.35)), although it did not reach statistical significance.
← all excerpts
The Study to Investigate COVID-19 Infection in People Living in Ireland (SCOPI): A seroprevalence study, June to July 2020.
1
—
—